Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures

Blood

Volumn 96, Issue 6, 2000, Pages 2219-2225

  Andersen, Niels S ^a   Larsen, Jørgen K ^a   Christiansen, Jette ^a   Pedersen, Lone B ^a   Christophersen, Nicolaj S ^a   Geisler, Christian H ^a   Jurlander, Jesper ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; DNA; FAS ANTIGEN; GLYCOPROTEIN GP 39; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; DNA CONTENT; DNA SYNTHESIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

EID: 0034665893     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2219.h8002219_2219_2225     Document Type: Article

References (41)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. Lymphoma classification - The gap between biology and clinical management is closing
3. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease
4. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission
5. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma
6. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lyrnphoma
7. The retinoblastoma protein pathway in cell cycle control and cancer
8. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
9. Genetic lesions in mantle cell lymphoma
10. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome
11. Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
12. The CD40 antigen and its ligand
13. CD40 and its ligand: Central players in B lymphocyte survival, growth, and differentiation
14. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: Relationship to the cell-cycle and role of the retinoblastoma protein
15. The role of CD40 in the regulation of humoral and cell-mediated immunity
16. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion
17. Mechanism of antigen-driven selection in germinal centres
18. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1
19. Prolonged phenotypic, functional and molecular change in group 1 Burkitt lymphoma cells on short-term exposure to CD40 ligand
20. Inhibition of human B-cell lymphoma growth by CD40 stimulation
21. Soluble CD40 ligand induces proliferation rather than apoptosis in primary human low-grade lymphomas: Implications for immunotherapy
22. Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells
23. Nerve growth factor released by CD40 ligand-transfected L cells: Implications for functional and phenotypic studies on CD40+ cells
24. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand
25. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor
26. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'
27. Proliferative response of mantle cell lymphoma stimulated by CD40 ligation and IL-4
28. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity
29. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal
30. Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity
31. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
32. Phase I study of rhuCD40 ligand in cancer patients
33. CD154 (CD40-ligand) gene immunization of chronic lymphocytic leukemia: A phase I study
34. Phase 1 trial with CD40-activated follicular lymphoma cells: A novel cellular vaccine strategy for B cell malignancies
35. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma
36. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
37. Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in-vitro BrdUrd incorporation into normal and malignant hematopoietic cells
38. Combined staining of BrdUrd (DNA synthesis) and cell surface antigen in PFA/detergent-fixed hematological cells
39. Pseudo-proliferation of hairy cell leukemia (HCL) in vitro
40. Mantle cell lymphoma: Biology, diagnosis and management
41. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype